Lyndsay A Harshman1, Amy J Kogon2,3, Matthew B Matheson4, Rebecca J Johnson5, Shlomo Shinnar6, Arlene C Gerson7, Bradley A Warady8, Susan L Furth2,3, Stephen R Hooper9, Marc B Lande10. 1. Division of Pediatric Nephrology, University of Iowa Stead Family Department of Pediatrics, 4037 Boyd Tower, 200 Hawkins Drive, Iowa City, IA, 52242, USA. lyndsay-harshman@uiowa.edu. 2. Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 3. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 4. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Division of Developmental and Behavioral Health, Children's Mercy Kansas City, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA. 6. Departments of Neurology, Pediatrics and Epidemiology and Population Health, Montefiore Medical Center, Albert Einstein College of Medicine, New York City, NY, USA. 7. Johns Hopkins University School of Medicine, Baltimore, MD, USA. 8. Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, MO, USA. 9. Department of Allied Health Sciences, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA. 10. University of Rochester Medical Center, Rochester, NY, USA.
Abstract
BACKGROUND: In adult chronic kidney disease (CKD), metabolic acidosis is associated with diminished cognition, notably executive function (EF). Data from the Chronic Kidney Disease in Children (CKiD) study demonstrate a risk for impairment of EF, a finding associated with heightened blood pressure variability (BPV). We sought to determine whether low serum bicarbonate is also associated with performance on tests of EF in pediatric CKD and to investigate potential interaction with BPV. METHODS: CKiD participants with serum bicarbonate, blood pressure, and selected cognitive measurements available were evaluated. An EF summary score was derived from scores on the Delis-Kaplan Executive Function System, Conners' Continuous Performance Test, and Digit Span Backwards subtest from the Wechsler Intelligence Scale for Children-IV-Integrated. Parents completed the Behavioral Rating Inventory of Executive Function (BRIEF) to yield a Global Executive Composite (GEC) score. Linear mixed models with bicarbonate and hypertension as predictors and linear regression with bicarbonate and BPV were used to predict EF level. RESULTS: Data were available for 865 children. Twenty-two percent had low bicarbonate (CO2 ≤ 20 mmol/L) at baseline. On multivariate analysis, there was no relationship between bicarbonate, hypertension, and EF. There was no significant CO2×hypertension interaction found. A significant interaction (p = 0.01) between high CO2 (≥ 26 mmol/L) and BPV was detected in the model with GEC as the EF outcome, indicating that while higher BPV was associated with worse EF in the low and normal CO2 groups, higher BPV was associated with better EF in the high CO2 group. CONCLUSIONS: Our analyses revealed an interaction between one measure of BPV and low bicarbonate on neurocognition in pediatric CKD, suggesting a potential role for control of both bicarbonate and blood pressure in preserving cognition in early CKD. Further research is needed to confirm and further define this association.
BACKGROUND: In adult chronic kidney disease (CKD), metabolic acidosis is associated with diminished cognition, notably executive function (EF). Data from the Chronic Kidney Disease in Children (CKiD) study demonstrate a risk for impairment of EF, a finding associated with heightened blood pressure variability (BPV). We sought to determine whether low serum bicarbonate is also associated with performance on tests of EF in pediatric CKD and to investigate potential interaction with BPV. METHODS:CKiDparticipants with serum bicarbonate, blood pressure, and selected cognitive measurements available were evaluated. An EF summary score was derived from scores on the Delis-Kaplan Executive Function System, Conners' Continuous Performance Test, and Digit Span Backwards subtest from the Wechsler Intelligence Scale for Children-IV-Integrated. Parents completed the Behavioral Rating Inventory of Executive Function (BRIEF) to yield a Global Executive Composite (GEC) score. Linear mixed models with bicarbonate and hypertension as predictors and linear regression with bicarbonate and BPV were used to predict EF level. RESULTS: Data were available for 865 children. Twenty-two percent had low bicarbonate (CO2 ≤ 20 mmol/L) at baseline. On multivariate analysis, there was no relationship between bicarbonate, hypertension, and EF. There was no significant CO2×hypertension interaction found. A significant interaction (p = 0.01) between high CO2 (≥ 26 mmol/L) and BPV was detected in the model with GEC as the EF outcome, indicating that while higher BPV was associated with worse EF in the low and normal CO2 groups, higher BPV was associated with better EF in the high CO2 group. CONCLUSIONS: Our analyses revealed an interaction between one measure of BPV and low bicarbonate on neurocognition in pediatric CKD, suggesting a potential role for control of both bicarbonate and blood pressure in preserving cognition in early CKD. Further research is needed to confirm and further define this association.
Authors: Stephen R Hooper; Arlene C Gerson; Robert W Butler; Debbie S Gipson; Susan R Mendley; Marc B Lande; Shlomo Shinnar; Alicia Wentz; Matthew Matheson; Christopher Cox; Susan L Furth; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2011-07-07 Impact factor: 8.237
Authors: F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler Journal: Brain Date: 2002-04 Impact factor: 13.501
Authors: Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2006-07-19 Impact factor: 8.237
Authors: Joseph T Flynn; Mark Mitsnefes; Christopher Pierce; Steven R Cole; Rulan S Parekh; Susan L Furth; Bradley A Warady Journal: Hypertension Date: 2008-08-25 Impact factor: 10.190
Authors: Susan R Mendley; Matthew B Matheson; Shlomo Shinnar; Marc B Lande; Arlene C Gerson; Robert W Butler; Bradley A Warady; Susan L Furth; Stephen R Hooper Journal: Kidney Int Date: 2014-09-24 Impact factor: 10.612
Authors: Anne M Murray; Yelena Slinin; David E Tupper; Sarah L Pederson; Cynthia Davey; David T Gilbertson; Paul Drawz; Ryan Mello; Allyson Hart; Kirsten L Johansen; Scott Reule; Rebecca Rossom; David S Knopman Journal: Am J Nephrol Date: 2022-04-28 Impact factor: 4.605
Authors: Stephen R Hooper; Rebecca J Johnson; Marc Lande; Matthew Matheson; Shlomo Shinnar; Amy J Kogon; Lyndsay Harshman; Joann Spinale; Arlene C Gerson; Bradley A Warady; Susan L Furth Journal: Front Neurol Date: 2021-12-20 Impact factor: 4.003
Authors: Pedro H Imenez Silva; Robert Unwin; Ewout J Hoorn; Alberto Ortiz; Francesco Trepiccione; Rikke Nielsen; Vesna Pesic; Gaye Hafez; Denis Fouque; Ziad A Massy; Chris I De Zeeuw; Giovambattista Capasso; Carsten A Wagner Journal: Nephrol Dial Transplant Date: 2021-12-28 Impact factor: 5.992